Mucormycosis in Diabetes

American Journal of Critical Care

Volumn 6, Issue 5, 1997, Pages 363-367

  Hopkins, Martha A ^a,b   Treloar, D M ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b INNOVISION COMMUNICATIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ADULT; ARTICLE; CASE REPORT; DEBRIDEMENT; FATALITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MUCORMYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEBRIDEMENT; DIABETES MELLITUS, TYPE 1; FATAL OUTCOME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MUCORMYCOSIS;

EID: 0031225771     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc1997.6.5.363     Document Type: Article

References (20)

1. Kemper J, Kuijper EJ, Mirck PG, Balm AJ. Recovery from rhinocerebral mucormycosis in a ketoacidotic diabetic patient: a case report. J Laryngol Otol. 1993;107:233-235.
2. De La Paz MA, Patrinely JR, Marines HM, Appling WD. Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Opthalmol. 1992;114:208-211.
3. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39:3-22.
4. Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg. 1988;114:791-794.
5. Atlas RM. Microbiology: Fundamentals and Applications. 2nd ed. New York, NY: Macmillan Publishing Co; 1988:313-317.
6. Tierney M, Baker A. Infections of the head and neck in diabetes mellitus. Infect Dis Clin North Am. 1995;9:195-216.
7. Moll GW, Raila FA, Liu GC, Conerly AW. Rhinocerebral mucormycosis in IDDM: sequential magnetic resonance imaging of long-term survival with intensive therapy. Diabetes Care. 1994;17:1348-1353.
8. Karam F, Chmel H. Rhino-orbital cerebral mucormycosis. Ear Nose Throat J. 1990;69:187-193.
9. Parfrey N. Improved diagnosis and prognosis of mucormycosis: a clinicopathologic study of 33 cases. Medicine. 1986;65:113-123.
10. Fisher EW, Toma A, Fisher PH, Cheesman AD. Rhinocerebral mucormycosis: use of liposomal amphotericin B. J Laryngol Otol. 1991;105:575-577.
11. Anand VK, Alemar G, Griswold JA. Intracranial complications of mucormycosis: an experimental model and clinical review. Laryngoscope. 1992;102:656-662.
12. Berkow R, ed. The Merck Manual. 16th ed. Rahway, NJ: Merck Research Laboratories; 1992:160-161.
13. Vazquez J, Sobel J. Fungal infections in diabetes. Infect Dis Clin North Am. 1995;9:97-116.
14. Smitherman KO, Peacock JE. Infectious emergencies in patients with diabetes mellitus. Med Clin North Am. 1995;79:53-77.
15. Berenguer J, Munoz P, Parras F, Fernandez-Baca V, Hernandez-Sampelayo T, Bouza E. Treatment of deep mycoses with liposomal amphotericin B. Eur J Clin Microbiol Infect Dis 1994;13:504-507.
16. Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis. 1988;10:551-559.
17. Clark AP. Diabetic ketoacidosis. In: Dossey BM, Guzzetta CE, Kenner CV, eds. Critical Care Nursing: Body-Mind-Spirit. Philadelphia, Pa: JB Lippincott Co; 1992:693-706.
18. Quenzer R, Allen S. Infections in the critically ill. In: Bongard FS, Sue DY, eds. Current Critical Care Diagnosis and Treatment. Norwalk, Conn: Lange; 1994:131-155.
19. Gardner ML, Godley PJ, Wasam SM. Sodium loading treatment for amphotericin B-induced nephrotoxicity. DICP. 1990;24:940-946.
20. Clements JS Jr, Peacock JE Jr. Amphotericin B revisited: reassessment of toxicity. Am J Med. 1990;88:22N-27N.